Strength of statistical evidence for the efficacy of cancer drugs: a Bayesian reanalysis of randomized trials supporting Food and Drug Administration approval-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strength of statistical evidence for the efficacy of cancer drugs: a Bayesian reanalysis of randomized trials supporting Food and Drug Administration approval

Published:2024-10 Issue: Volume:174 Page:111479
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Pittelkow Merle-Marie^ORCID,Linde Maximilian^ORCID,de Vries Ymkje Anna^ORCID,Hemkens Lars G.^ORCID,Schmitt Andreas M.^ORCID,Meijer Rob R.^ORCID,van Ravenzwaaij Don^ORCID

Funder

NWO

Publisher

Elsevier BV

Reference26 articles.

1. How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers’ views;Tafuri;Ann Oncol,2014

2. Clinical trial evidence supporting US Food and drug administration approval of novel cancer therapies between 2000 and 2016;Ladanie;JAMA Netw Open,2020

3. Assessment of the clinical benefit of cancer drugs receiving accelerated approval;Gyawali;JAMA Intern Med,2019

4. Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines;Salas-Vega;JAMA Oncol,2017

5. Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugs;Vokinger;Health Policy,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP